| Bioactivity | RC-106 is a proteasome inhibitor (IC50: 35 μM) and Sigma receptor modulator with anticancer activity. RC-106 has antiproliferative activity against cancer cells including glioblastoma (GB) and multiple myeloma (MM)[1]. |
| Invitro | RC-106 (60 μM; 24 h) 可抑制癌细胞活性[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> RC-106 相关抗体: Cell Viability Assay[1] Cell Line: |
| CAS | 1346216-50-9 |
| Formula | C26H29N |
| Molar Mass | 355.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Listro R, et al. Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents. Front Chem. 2020 Jun 30;8:495. |